Podcasts about technion israel institute

About Shay Perera:Shay is the co-founder and CTO of Navina, with a decade of experience in elite intelligence units of the Israel Defense Forces, where he applied artificial intelligence from theory to real-world solutions. He contributed heavily to hands-on R&D efforts while assuming significant leadership roles. Armed with a Master of Science in Electrical Engineering, specializing in machine learning, from the Technion – Israel Institute of Technology, Shay, alongside Ronen, earned the 2018 National Security Award for their groundbreaking work in AI.Things You'll Learn:AI is not just a futuristic concept but a current necessity for managing the overwhelming amount of healthcare data and streamlining clinical workflows, leading to improved patient outcomes and reduced administrative burdens for providers.The administrative burden is a significant pain point in healthcare, but AI can automate repetitive tasks, reduce the burden on providers, and streamline value-based care workflows, ultimately improving both clinical and economic outcomes.Emerging AI trends will change how physicians care for patients, saving time and enhancing knowledge of patient health.Clinical AI can act as a copilot, streamlining workflows and turning data into actionable insights for healthcare providers at the point of care and in the back office.  Healthcare organizations should focus on integrating AI solutions that can make physician life easier and ensure clinicians are involved as early as possible to gain trust in the process. Resources:Connect with and follow Shay Perera on LinkedIn.Learn more about Navina on their LinkedIn and website.Email Shay directly here.

Dr. Yoed Kenett studies the types of thinking and knowledge that support creativity. His research helps us understand the core mental processes of creativity, including associative thinking and question formulation. In this episode, we talk about the practical implications of his research and we show how that research can be used to enhance your creativity. He's done research at the Hebrew University at Jerusalem; Bar-Ilan University; Brown University; and the University of Pennsylvania. Since 2020, he's been a Senior Lecturer (Assistant Professor) in the Faculty of Data and Decision Sciences at The Technion: Israel Institute of Technology. 

Welcome to another episode of 'On the Couch'. This occasional podcast series of chats with brokers, CEOs, and fund managers aims to give you an insight into the investing world.In this podcast,  Henry Jennings is joined by Coby Hanoch, CEO of Weebit Nano Ltd (ASX: WBT) - a stock Henry has followed closely for years. It's been over a year since their last chat, so he's eager to hear about the progress. Coby brings a wealth of experience, with 15 years in engineering and engineering management, along with 26 years in sales management and executive roles. As Vice President of Worldwide Sales at Verisity, Coby was part of the founding team that grew the company to over $100 million in annual sales, leading to its acquisition by Cadence Design Systems (NASDAQ: CDNS). He later served as Vice President of Worldwide Sales at Jasper, where he doubled sales before its acquisition by Cadence. Coby holds a Bachelor of Science in Systems Design from the Technion - Israel Institute of Technology.Topics covered in the podcast include:Why was 2024 a little disappointing?The game-changing deal with onsemi - what does it mean for Weebit Nano?When can investors expect meaningful revenue?What's the outlook for 2025?Disclaimer: This is general advice only and you should consult your financial adviser regarding any of the thoughts, ideas or insights in this podcast.Why not sign up for a free trial? Get access to expert insights and research and become a better investor.

If sustainability and the human experience were at the forefront of architectural design, what changes would we see? Live from Autodesk University 2024, Nehama Schechter-Baraban joined the podcast for an important conversation on the intersection of technology and nature, how Revit plays into effective landscape architecture modeling, the potential for healthier and greener urban spaces, and how sometimes, all that's needed to innovate an industry is a new point of view. Nehama Schechter-Baraban is Chief Operations Officer of Arch-Intelligence. She is a landscape architect graduate of Technion - Israel Institute of Technology and a Revit expert. TODD TAKES Context Matters in Design:It's crucial for architects to consider how their buildings interact with the surrounding environment. Whether it's grading the landscape or understanding the site's topography, integrating context ensures the structure fits naturally into its setting, enhancing both the human experience and the project's efficiency. Sustainability as a Mindset:Sustainable design goes beyond specific tools; it's about designers having a mindset focused on environmental impact. From choosing native plants to minimizing land disturbance, sustainability is achieved by making conscious design choices that benefit the ecosystem and reduce costs. Simplifying Technology for Designers:The goal of innovation in design technology is to remove barriers, making tools more intuitive and accessible. This way, designers can focus on creativity, sustainability, and human-centric design rather than struggling with complex software. Thanks for listening! Please be sure to leave a rating and/or review and follow up our social accounts. Bridging the Gap Website Bridging the Gap LinkedIn Bridging the Gap Instagram Bridging the Gap YouTube Todd's LinkedIn   Thank you to our sponsors! Applied Software Applied Software LinkedIn   Other Relevant Links: Nehama's LinkedIn Arch-Intelligence  

Send us a textDr. Luba Perry, Ph.D. is Co-Founder and CEO of ReConstruct Bio ( https://wyss.harvard.edu/technology/reconstruct/ ), an innovative venture emerging from Harvard's Wyss Institute ( https://wyss.harvard.edu/team/advanced-technology-team/luba-perry/ ), aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and augmentation. With a multidisciplinary team of experts, the ReConstruct Bio team has developed the BioImplant—a living, bioengineered tissue created from the patient's own cells, to provide safer, more natural alternative to current standards, which are often associated with significant drawbacks and health concerns.Dr. Perry also serves as a Senior Scientist at the Wyss Institute for Biologically Inspired Engineering working at the 3D Organ Engineering Initiative since 2018 and is leading a Wyss Validation Project aiming to fabricate vascularized functional tissues for transplantation. Her interest is in tissue and organ engineering, focusing on vascularization and implantation studies utilizing complex surgical models. Dr. Perry's background is in molecular biology, pharmacology, and biomedical engineering, with a Bachelor of Science - BS, Biology, Master of Science - MS, Molecular Pharmacology, and a Doctor of Philosophy - PhD, Biotechnology, all from Technion - Israel Institute of Technology.  She also has industry experience in a vascular gene therapy company (MGVS, now VESSL Therapeutics).#LubaPerry #Harvard #WyssInstitute #ReConstructBio #Aesthetics #3DOrganEngineering #BreastReconstruction #BreastAugmentation #Vascularization #Innervation #Fat #AdiposeTissue #BreastImplants #Organogenesis #OrganEngineering #TissueEngineering #Bioengineering #Organs #Tissues #MolecularPharmacology #Breasts #Nipples#ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast  #STEM #Innovation #Technology #Science #ResearchSupport the show

Fascinated with science as a young child, Kira Radinsky was driven to make a meaningful impact on the world through technology. She faced rejection after rejection while building her first startup, but her resilience paid off when eBay acquired the company. Kira didn't stop there—she developed AI models that successfully predicted cholera outbreaks in Cuba and today, she continues to push the boundaries of AI and healthcare. As inspiring as her journey is, it's been far from easy. In this episode, Kira shares the lessons she's learned about resilience, pushing past rejection, and scaling startups. Kira Radinsky is the CEO and CTO of Diagnostic Robotics, known for her pioneering work in AI and predictive analytics. She gained global recognition for developing models that forecast major events, earning her recognition on Forbes' 30 Under 30 and MIT Technology Review's 35 Innovators Under 35. In this episode, Ilana and Kira will discuss: - How Kira built her first company despite major challenges - How AI is transforming global healthcare - The mindset shifts that fuel entrepreneurial success - Turning failures into career-defining moments - How to push forward when no one believes in your vision - Making bold leaps in a male-dominated industry - Staying committed when the path gets tough - Lessons from selling a startup to eBay - The power of persistence in scaling a business - Finding opportunity in uncertainty - Leveraging data to predict and prevent crises - Navigating risk and uncertainty with confidence - And other topics…   Kira Radinsky is the CEO and CTO of Diagnostic Robotics, an AI-driven healthcare company. Known for her groundbreaking work in data mining and predictive analytics, she gained international recognition for developing predictive models that forecast global events like disease outbreaks and political unrest, including predicting a cholera outbreak in Cuba. Kira began her studies at the Technion-Israel Institute of Technology at just 15 years old, later earning her PhD. She co-founded SalesPredict, an AI-driven company that was acquired by eBay in 2016, where she served as Chief Scientist and Director of Data Science. She has been honored in Forbes' 30 Under 30 and has been named one of MIT Technology Review's 35 Innovators Under 35. Connect with Kira: Kira's LinkedIn: https://www.linkedin.com/in/kira-radinsky/  Resources Mentioned: Diagnostic Robotics Website: https://www.diagnosticrobotics.com

Topic:A Thoughtful Leader   Guest: Arnon Kraft   Bio:    Arnon Kraft's most recent job was Chief Operating Officer at Payoneer, Inc.  He previously served as the Chief Executive Officer at Big 4 Strategic Consulting Ltd. from 2019 to 2021. Prior to that, he worked at Microsoft Corp. as the GM-Partner Management & Strategic Sourcing from 2012 to 2018. From 2008 to 2011, he held the position of Vice President-Operations at Modu Ltd. Prior to that he worked at SanDisk. Mr. Kraft obtained an MBA from Tel-Aviv University in 2000 and completed his undergraduate studies at Technion-Israel Institute of Technology in 1996.   *In this episode we learn the skills necessary to become an impactful manager and skillful worker plus how to multitask effectively.  

Dr. Doron Behar, MD, PhD is Founder & CEO of an end-to-end genetic platform company, Igentify ( https://www.igentify.com/ ), that provides a suite of digital tools designed to scale the provision of genomic medical services to more people worldwide, making it more accessible and actionable for clinicians, laboratories, and patients. Dr. Behar received his degrees from the Technion - Israel Institute of Technology. As an MD, he has dual specialization in Internal Medicine and Critical Care Medicine from Rambam Medical Center in Haifa, Israel. Dr. Behar's research areas of interest are across the broad range of evolutionary genomics, ancestry, phylogenetics, and translational genomics. He has been the leading author and co-author of numerous research papers in these areas. Dr. Behar is the former Chief Scientific Officer of Gene-by-Gene Ltd., a commercial genetic testing company. His expertise covers various aspects of mass genotyping, including regulation, privacy, genetic analysis, quality assurance, and more. Support the show

Dr. Yehuda Sabiner is a Gerrer Hasid and a graduate of the Technion–Israel Institute of Technology's Rappaport Faculty of Medicine. 00:00 - Introduction 16:14 - Interview

Minorities in cities worldwide confront disparities, advocating for rights within a dynamic interplay of urban planning and constitutional legal frameworks. How does the coevolution between planning and legal frameworks shape the status of minorities?  This lecture will dissect the coevolution of British constitutional rights and the status of minorities in the urban planning of London, post-WWII. It will explore how planning practices embed minority rights, shedding light on the transformation of political and legal frameworks into urban planning, and assessing their impact on state-minority relations. Orwa Switat is a visiting scholar at the Department of Urban and Environmental Policy and Planning at Tufts University. He is a scholar, practitioner, and activist in the realm of state-minority relations in urban planning. He holds a Ph.D. and M.Sc. degrees from the Department of Urban and Regional Planning at the Technion - Israel Institute of Technology. His research has critically examined the intersections of urban planning and state-minority relations. Complementing his advanced degrees, he possesses BAs in both Philosophy and Political Science from Haifa University.  In addition to his scholarly pursuits, Orwa has dedicated his work to promoting the rights of Palestinian communities in Israel in the context of planning, advising planners and civil society on spatial justice and inclusion. From 2019 to 2023, Orwa served on Haifa's municipal committee for historical preservation, influencing policies to honor and reflect the Arab Palestinian Heritage of the city. In addition to this audio, you can watch the video and read the full transcript of their conversation on Shareable.net – while you're there get caught up on past lectures. Cities@Tufts Lectures explores the impact of urban planning on our communities and the opportunities to design for greater equity and justice with professor Julian Agyeman.  Cities@Tufts Lectures is produced by Tufts University and Shareable.net with support from Barr Foundation and SHIFT Foundation. Lectures are moderated by Professor Julian Agyeman and organized in partnership with research assistants Deandra Boyle and Muram Bacare. Paige Kelly is our co-producer and audio editor, the original portrait of Mark Roseland was illustrated by Anke Dregnet, and the series is co-produced and hosted by Tom Llewellyn.  “Light Without Dark” by Cultivate Beats is our theme song.

(0:00) Intro.(1:28) About the podcast sponsor: The American College of Governance Counsel.(2:15) Start of interview.(3:16) Yifat's "origin story." (6:20) Yifat's bio and positions at the University of Haifa and Technion - Israel Institute of Technology.(8:00) About Elizabeth Pollman, Professor at the Penn Carey Law School at the U. of Pennsylvania.(9:57) About their article, Ousted (2023). "We use that term broadly to refer to being forced or pushed to step down from the CEO role, specifically that managerial role, despite having significant control. And what we're arguing is that there's a whole bunch of countervailing forces and factors that can work to limit the durability of the founder CEO's power and ultimately can lead to them resigning from that managerial role."(11:58) Examples of countervailing forces and factors to the founder/CEO power. Differences between public and private companies. Influence of voting rights.(15:20) Influence of margin loans (backed by founder stock) and secondary sales in corporate governance. *Reference to E41 with Maureen Farell on Cult of We (Aug 2021).(19:31) Conflict with regulators, investors and other stakeholders (example: Uber). *Reference to Elizabeth Pollman's article on Regulatory Entrepreneurship. (22:19) On employee pressure in corporate governance.(23:00) On OpenAI's board debacle (involving Sam Altman's ouster and reinstatement). (29:31) Other founder/CEO cases referenced in Ousted. *Mention of E64 with Keir Gumps, involved in Uber's governance clean-up. Cases of Elizabeth Holmes (Theranos) and Sam Bankman-Fried (FTX). On externalities from lack of corporate governance in startups, particularly unicorns. The impact of the Power Law in VC-backed companies.(36:26) Take-aways from their article Ousted. Gap between academia and practice.(40:04) Elizabeth Pollman's article Startup Failure. *Reference to E3 with Elizabeth Pollman on Startup Governance and Regulatory Entrepreneurship (May 2020)."[I]t's really important that law and culture facilitate the efficient flow of the failure of venture-backed startups and that failed startups can do so with honor because that's what sustains our system in a big way, out of which comes these few successes. But we also have to have a way of dealing with lots of failed startups (ie. M&A, acquihires, ABCs, and liquidation)."*Reference to my newsletter describing a time of "downrounds, shutdowns and recaps" on a monthly basis.(44:28) Yifat Aran's article The RSU Time Bomb: Regulating Startup Equity Compensation in the Unicorn Era. Triggered by Stripe's downround in March 2023 (raising $6.5 billion at $50 billion valuation).(52:51)  On current equity compensation practices and the private/public market divides.(54:51) Consequences of startups staying private for longer (SPL) or forever.- Rapid fire questions for Yifat Aran:(58:31) Books that have greatly influenced her life: The Death of Ivan Ilyich by Leo Tolstoy (1886)(59:56) Her mentors: Dorit Beinisch (Former President of the Supreme Court of Israel)Joe Grundfest, Stanford Law School.Elizabeth Pollman, Penn Carey Law School.(01:02:30) Quotes that she thinks of often or lives her life by: "I believe that you can achieve everything, but you aren't likely to achieve everything at the same time."(01:03:13) An unusual habit or absurd thing that she loves: chic flicks and gummy bears to write papers.(01:03:46) A living person she admires: Arthur Rock.Elizabeth Pollman is a Professor of Law and the Co-Director of the Institute for Law & Economics at the University of Pennsylvania Carey Law School. She teaches and writes in the areas of corporate law and governance, as well as startups, venture capital, and entrepreneurship.Yifat Aran is an Assistant Professor of Law at the University of Haifa. She is also a lecturer in the MBA program at the Technion, Israel Institute of Technology, and a research fellow at the Rutgers Institute for the Study of Employee Ownership and Profit Sharing. She is primarily interested in corporate law and governance and securities regulation, with a focus on venture capital and entrepreneurship. __This podcast is sponsored by the American College of Governance Counsel. You can follow Evan on social media at:Twitter: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__You can join as a Patron of the Boardroom Governance Podcast at:Patreon: patreon.com/BoardroomGovernancePod__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Welcome to the final episode of 'On the Couch' for 2023. This occasional podcast series of chats with brokers, CEOs, and fund managers aims to give you an insight into the investing world.In this episode, Henry Jennings is delighted to be joined by Coby Hanoch, CEO at Weebit Nano Ltd (ASX: WBT). A stock he has followed for a long time.Coby has 15 years' experience in engineering and engineering management, and 26 years' experience in sales management and executive roles. He was Vice President Worldwide Sales at Verisity, where he was part of the founding team and grew the company to over $100M in annual sales, which facilitated its acquisition by Cadence Design Systems (NASDAQ: CDNS). He was also Vice President Worldwide Sales at Jasper, doubling sales before it was acquired by Cadence. Coby holds a Bachelor of Science in Systems Design from Technion – Israel Institute of Technology.Some of the topics discussed:How is WBT going with the new technology? What is ReRAM?When will we see meaningful revenues?What products will the technology be used in with large volumes?What does 2024 hold in store?Why is Israel such a tech powerhouse?How can Australia copy that lead and become better at tech?Let's talk AI. Where do you see the opportunities?Is WBT a part of that AI story, or is this just part of the existing technology suite?Where do you think we will be with AI in a years' time?Who else is working on ReRAM technology?Disclaimer: This is general advice only and you should consult your financial adviser regarding any of the thoughts, ideas or insights in this podcast.Why not sign up for a free trial? Get access to expert insights and research and become a better investor.Discover your unique investor type with Marcus Today. We invite you to take part in our FREE educational series.

This week's guest is Itamar Falcon, CEO and Co-Founder of Coho AI, brings vast experience from Microsoft and Google, enhanced by his academic journey at the Technion - Israel Institute of Technology. Guided by a genuine passion for the potential of data, Itamar is focused on developing practical solutions that improve how companies use their data to foster growth and deepen customer engagement. His aim at Coho AI is straightforward: to help businesses unlock the full value of their data to boost revenue, engagement, and customer lifetime value. --- Support this podcast: https://podcasters.spotify.com/pod/show/uncharted1/support

Rachel Diamant co-founded EmendoBio and serves as Chief Business Officer. Rachel is responsible for EmendoBio's IP strategy, which she designed to generate an extensive patent portfolio to cover various novel aspects of the technology and products while also expertly navigating the IP space. In her role as CBO, Rachel also builds EmendoBio's pipeline of clinical programs and the academic and industrial collaborations and partnerships for the pre/clinical development of EmendoBio's selected indications and genomic targets. Rachel has extensive experience in constructing IP strategy that is designed to serve business objectives based on careful competitive landscaping to reduce risks and maximize value. In the private market, Rachel has been a consultant for numerous biotechnology and medical device companies and accumulated extensive expertise in IP mining, strategic portfolio design and hands-on portfolio management. Rachel holds an MSc in Neurobiology from the Weizmann Institute of Science and a Biotechnology Engineering degree from the Technion Israel Institute of Technology. --- Support this podcast: https://podcasters.spotify.com/pod/show/freeman-means-business/support

Podcast: ICS Cyber Talks PodcastEpisode: Cyber Women-3: Sara Bitan D.Sc Co-Founder & CEO @CyCloak on women in cyber & PLC vulnerability researchPub date: 2023-08-22Nachshon Pincu hosts Sara Bitan D.Sc, Co-Founder and CEO at CyCloak, PLC (controllers) vulnerability researcher at Technion - Israel Institute of Technology, and Blackhat speaker, in a conversation about her experience as a woman in cyber. And the need for PLC vulnerabilities research. Way must a woman demonstrate higher abilities than a man to receive a higher initial credit? Following the previous question, you said, "A woman has to work harder than a man, there is no glass ceiling, but the road is more difficult." Why is that? You told me that when you started your studies at the Technion, 50% of the students in your class were women. Where did they disappear in the world of employment? You investigate the controller's weaknesses to show the industry, especially the controller manufacturers, their direction is wrong. Please explain. From your research, the weakness that runs through all the studies is an attack on inscription key management. Please explain in a language that we laypeople can understand. There is no technological challenge in attacking controllers; all the attacker needs, is the right motivation. How has that motivation? The window of opportunity for a direct OT attack is opening more and more, mainly because of the connection of the OT network to the corporate network and the cloud. Does this mean OT attacks can only come through the corporate network/cloud? The technological bar for cyber attacks, including OT attacks, is becoming lower than before. Attackers didn't know how to attack OT's old school. Today the situation has changed, and a new front has opened, like the attacks on Black Energy and the dam in Upstate New York. What to do? And More נחשון פינקו מארח את ד"ר שרה ביתן, ד"ר למדעים, מייסדת שותפה ומנכ"לית סייקלוק, חוקרת חולשות בקרים בטכניון ודוברת בבלאקהט, בשיחה על הניסיון שלה כאישה בסייבר. והצורך במחקר חולשות בבקרים. מדוע אישה חייבת להפגין יכולות גבוהות יותר מגבר כדי לזכות בהכרה? בעקבות השאלה הקודמת אמרת "אישה צריכה לעבוד קשה יותר מגבר, אין תקרת זכוכית, אבל הדרך יותר קשה". למה? אמרת לי שכשהתחלת את לימודיך בטכניון, 50% מהתלמידים בכיתה שלך היו נשים. לאן הם נעלמו בעולם התעסוקה? את חוקרת את החולשות של הבקר כדי להראות לתעשייה, במיוחד ליצרני הבקרים, שהכיוון שלהם שגוי. אנא הסברי? מהמחקר שלך, הבעיה שעוברת כחוט השני בכל המחקרים היא התקפה על ניהול מפתחות הצפנה, אנא הסבירי בשפה שאנו ההדיוטות יכולים להבין. "אין אתגר טכנולוגי בתקיפת בקרים, כל מה שהתוקף צריך הוא את המוטיבציה הנכונה". למי יש את המוטיבציה הזו? חלון ההזדמנויות למתקפות ישירות על מערכות תפעוליות נפתח יותר ויותר, בעיקר בגלל החיבור של הרשתות התפעוליות לרשת הארגונית ולענן. האם זה אומר שהתקפות על הסביבות התפעוליות יכולות להגיע רק דרך הרשת הארגונית או ענן? הרף הטכנולוגי למתקפות סייבר, כולל מתקפות על סביבות תפעוליות, הופך נמוך מבעבר. התוקפים לא ידעו איך לתקוף את הסביבות התפעוליות הישנות, כיום המצב השתנה, ונפתחה חזית חדשה, כמו ההתקפות על בלאק אנרג'י והסכר באפסטייט ניו יורק. מה עושים? ועודThe podcast and artwork embedded on this page are from Nachshon Pincu, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

Nachshon Pincu hosts Sara Bitan D.Sc, Co-Founder and CEO at CyCloak, PLC (controllers) vulnerability researcher at Technion - Israel Institute of Technology, and Blackhat speaker, in a conversation about her experience as a woman in cyber. And the need for PLC vulnerabilities research. Way must a woman demonstrate higher abilities than a man to receive a higher initial credit? Following the previous question, you said, "A woman has to work harder than a man, there is no glass ceiling, but the road is more difficult." Why is that? You told me that when you started your studies at the Technion, 50% of the students in your class were women. Where did they disappear in the world of employment? You investigate the controller's weaknesses to show the industry, especially the controller manufacturers, their direction is wrong. Please explain. From your research, the weakness that runs through all the studies is an attack on inscription key management. Please explain in a language that we laypeople can understand. There is no technological challenge in attacking controllers; all the attacker needs, is the right motivation. How has that motivation? The window of opportunity for a direct OT attack is opening more and more, mainly because of the connection of the OT network to the corporate network and the cloud. Does this mean OT attacks can only come through the corporate network/cloud? The technological bar for cyber attacks, including OT attacks, is becoming lower than before. Attackers didn't know how to attack OT's old school. Today the situation has changed, and a new front has opened, like the attacks on Black Energy and the dam in Upstate New York. What to do? And More נחשון פינקו מארח את ד"ר שרה ביתן, ד"ר למדעים, מייסדת שותפה ומנכ"לית סייקלוק, חוקרת חולשות בקרים בטכניון ודוברת בבלאקהט, בשיחה על הניסיון שלה כאישה בסייבר. והצורך במחקר חולשות בבקרים. מדוע אישה חייבת להפגין יכולות גבוהות יותר מגבר כדי לזכות בהכרה? בעקבות השאלה הקודמת אמרת "אישה צריכה לעבוד קשה יותר מגבר, אין תקרת זכוכית, אבל הדרך יותר קשה". למה? אמרת לי שכשהתחלת את לימודיך בטכניון, 50% מהתלמידים בכיתה שלך היו נשים. לאן הם נעלמו בעולם התעסוקה? את חוקרת את החולשות של הבקר כדי להראות לתעשייה, במיוחד ליצרני הבקרים, שהכיוון שלהם שגוי. אנא הסברי? מהמחקר שלך, הבעיה שעוברת כחוט השני בכל המחקרים היא התקפה על ניהול מפתחות הצפנה, אנא הסבירי בשפה שאנו ההדיוטות יכולים להבין. "אין אתגר טכנולוגי בתקיפת בקרים, כל מה שהתוקף צריך הוא את המוטיבציה הנכונה". למי יש את המוטיבציה הזו? חלון ההזדמנויות למתקפות ישירות על מערכות תפעוליות נפתח יותר ויותר, בעיקר בגלל החיבור של הרשתות התפעוליות לרשת הארגונית ולענן. האם זה אומר שהתקפות על הסביבות התפעוליות יכולות להגיע רק דרך הרשת הארגונית או ענן? הרף הטכנולוגי למתקפות סייבר, כולל מתקפות על סביבות תפעוליות, הופך נמוך מבעבר. התוקפים לא ידעו איך לתקוף את הסביבות התפעוליות הישנות, כיום המצב השתנה, ונפתחה חזית חדשה, כמו ההתקפות על בלאק אנרג'י והסכר באפסטייט ניו יורק. מה עושים? ועוד

Eran Yahav is the cofounder and CTO of Tabnine, an AI assistant that developers can use to build software faster. He's a professor at Technion - Israel Institute of Technology and was previously a researcher at IBM. He has a PhD in Computer Science from Tel Aviv University. In this episode, we cover a range of topics including: - Tasks in software development - What tasks are likely to benefit from LLMs - The launch of Tabnine Chat - Characteristics of a good AI coding assistant - Making AI coding assistants context-aware - Generic LLMs vs domain specific LLMs - AI copilot for devops work Eran's favorite book: Catch-22 (Author: Joseph Heller)--------Where to find Prateek Joshi: Newsletter: https://prateekjoshi.substack.com Website: https://prateekj.com LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19 Twitter: https://twitter.com/prateekvjoshi 

Mickey Balter is the CEO & Co-Founder of Oriient, an in-store navigation technology provider that offers hyper-accurate indoor positioning using the earth's magnetic field and built-in smartphone sensors. Mickey is a serial entrepreneur and a veteran of the Israeli semiconductor industry, with over 20 years of experience in combining deep technology to solve business challenges. Prior to founding Oriient, Mickey founded and led Scientra which developed the world's fastest High-Frequency Trading platform. Before that Mickey held senior leadership positions at Siverge Networks and Broadlight (acquired by Broadcom).   In this conversation we touch on: - The beginning of indoor GPS. - Practical applications of the technology, inside and outside large retailers. - The principles that guide the staff at Oriient. - The need for speed and the willingness to share. - The future vision for Oriient and its GPS tech.   Mickey started his career in the IDF's elite cyber-security unit. Mickey holds an MBA from Tel-Aviv University and a B.Sc. in Electrical Engineering from Technion - Israel Institute of Technology. Connect with Mickey: Website: https://www.oriient.me/ Social media: https://www.linkedin.com/company/oriient/   Mickey's LinkedIn: https://www.linkedin.com/in/balterm/   Connect with Allison: LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/ Website: DisruptiveCEONation.com Twitter: @DisruptiveCEO    #futurist #CEO #startup #startupstory #founder #founderstory #business #businesspodcast #podcast         Learn more about your ad choices. Visit megaphone.fm/adchoices

If you're a YJP (Young Jewish Professional), chances are your life is awesome. You may be hit up to go bowling with some friends. Guess what? It's a Moishe House event and it's free of charge! You may later sign up for a young adult retreat through NuRoots to tap into Torah Study while exploring the great outdoors. You will likely run into that old friend from BBYO whom you enjoyed Hebrew school with at your local synagogue. You may host a Shabbat event and even more amazing: The price of that meal will be subsidized by OneTable (CEO and Founder Aliza Kline was on this podcast). The possibilities for Jews are endless! You don't have to be in your 20s to enjoy these programs. You can be a recent parent, a senior citizen, or even a newborn. There is a guarantee that a Jewish non-profit impacted your life one way or another. Why is this network so strong? Gary S. Cohn of Painted Rock Advisors is a non-profit and philanthropic advisor. He helps organizations run smoothly while helping entrepreneurs and philanthropists allocate their wealth to the right organizations. With these contributions, Cohn has impacted the Jewish and non-Jewish world in numerous ways. Chaz Volk, host of Bad Jew, interviews Cohn to understand why it's more than just money that makes these non-profits run. Volk, having produced Cohn's Podcast, The Road to Philanthropy, is aware of his passion and drive, helping Gary showcase his talents to the Bad Jew community. About Gary S. Cohn: Gary brings over thirty years of non-profit and development experience to his work as a trusted advisor. Gary became the Executive Director of Temple Emanu-El in San Francisco from 1991-2007. Temple Emanu-El is one of the leading congregations in Reform Judaism with over 2,000 families founded in 1850. There he managed all business aspects of the congregation plus membership services and program. Gary was responsible for an annual budget of $15 million and an endowment equities and real estate of over $40 million. In 2008 he became the Regional Director of American Technion Society in the Pacific Northwest (Silicon Valley to Seattle) raising about $15-$20 million a year to support the Technion-Israel Institute of Technology. From 20015 until 2020 Gary held Senior Vice President/Major Gift roles at Alzheimer's Association and the Jewish Agency for Israel. In 2020, Gary founded Painted Rock Advisors. Painted Rock Advisors provides services to the philanthropic and non-profit communities. His podcast, The Road to Philanthropy debuted in 2021 and now has over 6,000 listeners. Gary serves on the Board of Directors of Hillel 818 and Safe Parking Los Angeles where he is Chair of Governance at both non-profits. Previously served on the Board of Directors of the American Red Cross-Bay Area, the San Francisco Food Bank and Bentley School. He was on the Advisory Board of City National Bank in Northern California from 2000-2007. Gary is a graduate of California State University at Long Beach and received his BS from the College of Business. He was honored as Alumnus of the Year for the College of Business in 2009. Gary lives in Woodland Hills with his partner, Paula and has a daughter, Erica, who works in the entertainment industry. Connect with Gary S. Cohn: https://linktr.ee/RoadToPhilanthropy www.paintedrockadvisors.com Connect with Bad Jew: Join our online community HERE: https://linktr.ee/badjew BadJewPod@gmail.com Ig @BadJewPod TikTok @BadJewPod

Do you have what it takes to climb into the C-Suite? If you make it there will you stay? A recent study shows that for every woman at the director level who gets promoted, two women directors are choosing to leave their company. Join us as we share our suspicions as to why. Give WISEcast some monthly listener support or make a one-time donation  →Paypal. Rachel Diamant is the co-founder and Chief Business Officer of Emendo Biotherapeutics, a next-generation gene editing company that targets genes with unprecedented levels of precision and efficacy. Operating in a field that is largely dominated by men, Rachel has emerged as a true innovator and leader, helping to position Emendo as a key player that is set to disrupt the landscape of gene therapies in the coming years. Rachel drives Emendo's strategy, science, and clinical programs essential to positioning Emendo as an attractive opportunity for investors and partners alike. Rachel holds an MSc in Neurobiology from the Weizmann Institute of Science and a Biotechnology Engineering degree from the Technion Israel Institute of Technology. WISEcast is featured as one of the top 10 podcasts from the 60 Best Women in STEM Podcasts by Feedspot! Check out The Wisest Children on YouTube and see how our young scientist proteges are making science accessible and fun through some STEM activities for kids! You can connect with us on: Instagram, Facebook, Twitter, YouTube, LinkedIn or by email at thewisestwomen@gmail.com. --- Send in a voice message: https://podcasters.spotify.com/pod/show/thewisestwomen/message Support this podcast: https://podcasters.spotify.com/pod/show/thewisestwomen/support

Researching Transit comes to you again from the Conference on Advanced Systems in Public Transport (CASPT2022) in Tel Aviv, Israel. In this episode Professor Graham Currie met with another of the conference organisers, Professor Avi Ceder. Avi is the Emeritus Professor at the Faculty of Civil and Environmental Engineering and at the Transportation Research Institute, Technion Israel Institute of Technology. He is also a former Zhi-xing Professor at Beijing Jiaotong University (BJTU) and Honorary Professor at the University of Auckland, New Zealand. Avi is an expert on public transport scheduling, and the author of Public Transit Planning and Operation: Theory, Modeling and Practice. Graham and Avi first talk about Avi's background and experience as a bus driver, PhD student, academic and now Emeritus Professor. Avi got into transit scheduling having taught operations management subjects, and as a consultant to an Israeli bus company prior to development of computerised scheduling tools. Graham and Avi discuss the development of, and research into, transit scheduling theory and tools. They then move onto discuss a recent paper Avi authored on Syncing sustainable urban mobility with public transit policy trends based on global data analysis in Nature Scientific Reports (https://doi.org/10.1038/s41598-021-93741-4). Avi outlines four issues with road traffic discussed in this paper: crashes, congestion, pollution and space used by parked vehicles. He also discusses the paper's study of 17 cities, and exploration of what the shift to autonomous vehicles might mean for transportation, transit and the number of vehicles that will be needed in the future. Graham and Avi discuss some of the opportunities that are presented by COVID-19, autonomous vehicles and other shifts. Avi's Nature paper discusses how autonomous vehicles, if publicly owned / shared, may allow cities to reallocate road and parking space to other uses. He and Graham discuss how a future with widespread private ownership and use might, instead, result in more vehicles, lower occupancy and increase congestion. Later in the episode Avi discusses his work on deficit functions that can be use in the optimisation of vehicle numbers and minimisation of waiting time. Avi also outlines the concept of Just Noticeable Difference (JND), being the threshold at which people might distinguish between different costs, waiting times or other aspects of alternative transport options. This might be used as an input to mobile phone-based trip planning software, to personalise route recommendations to individual preferences in real-time. Find out more about Avi and his work at his: Avi's webpage at the Technion – Israel Institute of Technology at https://ceder.net.technion.ac.il/ Avi's webpage as an International Associate of Monash's Public Transport Research Group (PTRG) at http://publictransportresearchgroup.info/our-team/international-associates/avi-ceder-2/ Avi's publications at: World Transit Research at https://www.worldtransitresearch.info/do/search/?q=author_lname%3A%22Ceder%22&start=0&context=1060035&facet=#query-results Have feedback? Find us on twitter and Instagram @transitpodcast or using #researchingtransit Music from this episode is from https://www.purple-planet.com

In today's CRUZAMENTO Podcast, André Correia e Daniel Guedelha talked with Eyal Zimlichman about the hospital of the future, a world where healthcare doesn't have an address, and the emerging field of multiomics, which involves analyzing multiple layers of biological information to tailor treatments to individual patients. Prof. Eyal Zimlichman is an internal medicine physician, a health care executive and a researcher focused on assessing and improving health care quality and value, patient engagement and patient safety. Prof. Zimlichman currently serves as Chief Transformation Officer and Chief Innovation Officer at Sheba Medical Center, Israel's largest hospital. In this position he oversees the transformation efforts carried out at the Medical Center as it aims to redesign healthcare to be focused on patients, while being more effective, efficient and equitable. For these reasons, Prof. Zimlichman founded Sheba's global innovation program (ARC – Accelerate, Redesign and Collaborate). Prior to this Prof. Zimlichman held the position of Chief Medical Officer and before that as Chief Quality Officer, both at Sheba. Preceding his work at Sheba, Prof. Zimlichman held the position of Lead Researcher at Partners Health Care Clinical Affairs Department in Boston where he was involved in the efforts to bring about a strategic care redesign initiative. In that capacity, Prof. Zimlichman established their program for collecting and reporting patient reported outcomes across the continuum of care, a program that earned international appraisal. During that time, Prof. Zimlichman held an appointment at Brigham and Women's Hospital and Harvard Medical School affiliated Center for Patient Safety Research and Practice, where he conducted research on implementing technology to improve quality and patient safety. Prof. Zimlichman is a founding member of the International Academy of Quality and Safety in Health Care and an International Expert at the International Society of Quality in Healthcare (ISQua). He also served as an advisor to the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services. In 2007 Prof. Zimlichman was selected as a member of Sheba's Talpiot Medical Leadership Program, a program aimed at advancing the brightest young physicians into leadership roles. In 2017 he was appointed head of the program. Prof. Zimlichman is a graduate of the Harvard School of Public Health Master of Science in Healthcare Management program and has earned his MD at the Technion Israel Institute of Technology. Other relevant references | Outras referências relevantes: Sheba Tel HaShomer City of Health Contacts | Contactos: CruzamentoPodcast.com cruzamentopodcast@gmail.com LinkedIN: Cruzamento Twitter: @cruzamentofm Facebook: @podcastcruzamento Instagram: @cruzamentopodcast YouTube: Podcast Cruzamento

Dr. Joshua Schiffman is the CEO and Co-Founder of Peel Therapeutics and has taken the understanding of the natural resistance to cancer by elephants to develop PEEL-224 to attack tumors. Using a plant toxin and modifying existing approaches, Peel has created a drug that increases the amount of the drug that gets to the cancer cells with reduced side effects.   Joshua explains, "Peel is actually the Hebrew word for elephant. So that's why we call ourselves Peel Therapeutics. My Co-Founder, Dr. Avi Schroeder, is from the Technion-Israel Institute of Technology in Israel. While we were working on the elephant drug, we realized, you know what, it's more than just elephants. Looking around nature, we understand that evolution has had hundreds of millions of years to perfect, in some cases, perfect cancer-fighting protein or peptide or anti-inflammatory molecule. Our lead drug, which we call PEEL-224, actually works really well targeting the DNA repair mechanism in cancer cells." "This DNA repair mechanism is called topoisomerase 1. And by blocking it, we're able to actually ensure that cancer cells essentially self-destruct. At Peel, we say that we like to engineer nature better than evolution intended. So, in the case of PEEL-224, we've taken this plant toxin, it's called camptothecin. It comes from an ancient Chinese tree called the Happy Tree, and we've modified it so that it can avoid chemoresistance. So, in other words, you give this drug to the patient, which goes to the tumor, and the tumor cell can't spit it out anymore. And we're seeing remarkable early results in mice and now have begun a clinical trial." @peel_tx #PeelTherapeutics #PeopleofPeel #Cancer #Inflammation #PEEL224 #Nature #Biotech #NaturesMoleculesIntoMedicine  peeltx.com  Download the transcript here

Dr. Joshua Schiffman is the CEO and Co-Founder of Peel Therapeutics and has taken the understanding of the natural resistance to cancer by elephants to develop PEEL-224 to attack tumors. Using a plant toxin and modifying existing approaches, Peel has created a drug that increases the amount of the drug that gets to the cancer cells with reduced side effects.   Joshua explains, "Peel is actually the Hebrew word for elephant. So that's why we call ourselves Peel Therapeutics. My Co-Founder, Dr. Avi Schroeder, is from the Technion-Israel Institute of Technology in Israel. While we were working on the elephant drug, we realized, you know what, it's more than just elephants. Looking around nature, we understand that evolution has had hundreds of millions of years to perfect, in some cases, perfect cancer-fighting protein or peptide or anti-inflammatory molecule. Our lead drug, which we call PEEL-224, actually works really well targeting the DNA repair mechanism in cancer cells." "This DNA repair mechanism is called topoisomerase 1. And by blocking it, we're able to actually ensure that cancer cells essentially self-destruct. At Peel, we say that we like to engineer nature better than evolution intended. So, in the case of PEEL-224, we've taken this plant toxin, it's called camptothecin. It comes from an ancient Chinese tree called the Happy Tree, and we've modified it so that it can avoid chemoresistance. So, in other words, you give this drug to the patient, which goes to the tumor, and the tumor cell can't spit it out anymore. And we're seeing remarkable early results in mice and now have begun a clinical trial." @peel_tx #PeelTherapeutics #PeopleofPeel #Cancer #Inflammation #PEEL224 #Nature #Biotech #NaturesMoleculesIntoMedicine  peeltx.com  Listen to the podcast here

Yogev Shifman is one of the co-founders of Exodigo, a successful AI company that aims to solve the underground challenge, providing underground risk management services. Before joining Exodigo, he worked at Buildots, another thriving AI company that serves the construction industry.Prior to his tenure at Buildots, Yogev served as a distinguished officer in the Israeli intelligence corps. He directed multi-national and multi-disciplinary programs for real-time embedded hardware and software systems at one of Israel's top deep tech units. He was recognized with multiple awards for his contributions to the field.Yogev holds a B.Sc in computer software engineering from Technion - Israel Institute of Technology (the Israeli MIT), and he began his career at Intel Corporation before pursuing an MBA in entrepreneurship and technology at Tel Aviv University. Connect with Behind Company Lines and HireOtter Website Facebook Twitter LinkedIn:Behind Company LinesHireOtter Instagram Buzzsprout

My guest today is Gary Cohn. Gary brings over thirty years of non-profit and development experience to his work as a trusted advisor. He began his work as a middle market banker from 1977-1992. After being trained in credit, he led a sales and marketing team for several large California banks leaving in 1992 to move into the non-profit sector.   Gary became the Executive Director of Temple Emanu-El in San Francisco. Temple Emanu-El, founded in 1850, is one of the leading congregations in Reform Judaism, with over 2,000 families. Gary was responsible for an annual budget of $15 million and endowment equities and real estate of over $40 million.   In 2008 he became the Regional Director of the American Technion Society in the Pacific Northwest, raising funds to support the Technion-Israel Institute of Technology. From 20015 until 2020, Gary held Senior Vice President/Major Gift roles at the Alzheimer's Association and the Jewish Agency for Israel.   In 2020, Gary founded Painted Rock Advisors. Painted Rock Advisors provides services to the philanthropic and non-profit communities. His podcast, The Road To Philanthropy, debuted in 2021 and now has over 4,500 listeners.   Gary previously served on the Board of Directors of the American Red Cross-Bay Area, the San Francisco Food Bank, and Bentley School. He currently serves on the Board of Directors of Hillel 818 and Safe Parking Los Angeles and is Chair of Governance at both nonprofits.   Gary attended California State University at Long Beach, where he received his BS from the College of Business. He was honored as Alumnus of the Year for the College of Business in 2009.   Gary lives in Woodland Hills with his partner, Paula, and has a daughter, Erica, who works in the entertainment industry.   Here's what to expect during the episode: What does leadership mean? What are the role and responsibilities of an executive director? How can you ensure board effectiveness? Why is it essential to conduct self-evaluation? What is the role of the board chair? Why is communication important in an organization? Connect with Gary Cohn! Website: https://www.paintedrockadvisors.com/ Emails: mzt8877@gmail.com | paintedrockadvisors@gmail.com   Get 6 Steps You Must Know to Unleash the Potential of Your Nonprofit Board, go here: https://hilandconsulting.org/6stepsreport.    Mary's book is available on Amazon or wherever books are sold: Love Your Board! The Executive Directors' Guide to Discovering the Sources of Nonprofit Board Troubles and What to Do About Them.   Be sure to subscribe to Inspired Nonprofit Leadership so that you don't miss a single episode, and while you're at it, won't you take a moment to write a short review and rate our show? It would be greatly appreciated!     Let us know the topics or questions you would like to hear about in a future episode. You can do that and follow us on Facebook.   Connect with Mary! LinkedIn: https://www.linkedin.com/in/maryhiland Inspired Nonprofit Leadership Facebook Group: https://tinyurl.com/inspirednonprofitleadership Company Facebook: https://www.facebook.com/hilandconsulting Website: https://www.hilandconsulting.org

"Brands will be able to sell their products for higher prices than they do today because, let's say, 82% of millennials are willing to pay much more to get a personalized product."Today's episode of The Shape of Work podcast features Gal Saar, CEO at Capsulab Ltd. Gal Saar has 13 years of overall experience, having earned a B.Sc in Information Systems from Ben-Gurion University of the Negev and an M.E from Technion-Israel Institute of Technology. He has worked with El Al and also served as the Development Project Manager at Elta Systems Ltd.In this episode, Gal Saar discusses what it's like to introduce a new product into the market and the various factors involved in and around this process.Episode Highlights:The importance of understanding what consumers are looking forInsights into the product marketHow to make a growing company successfulThe work involved in product development and marketingFollow Gal on Linkedin Produced by: Priya BhattPodcast Host: Moshe VhanunuAbout Springworks:Springworks is a fully-distributed HR technology organisation building tools and products to simplify recruitment, onboarding, employee engagement, and retention. The product stack from Springworks includes:SpringVerify— B2B verification platformEngageWith— employee recognition and rewards platform that enriches company cultureTrivia — a suite of real-time, fun, and interactive games platforms for remote/hybrid team-buildingSpringRole — verified professional-profile platform backed by blockchain, andSpringRecruit — a forever-free applicant tracking system.Springworks prides itself on being an organisation focused on employee well-being and workplace culture, leading to a 4.8 rating on Glassdoor for the 200+ employee strength company.

Ido Gonen is the Chief Technology Officer and co-founder of Exodigo, the non-intrusive, multi-sensing subsurface imaging platform. Prior to Exodigo, Ido led multiple engineering teams focusing on innovative, inter-unit R&D projects inside one of Israel's elite deep tech units, where he started his career as a software engineer. Ido graduated cum laude from Technion - Israel Institute of Technology with a B.Sc in software engineering and an M.Sc in computer science. He also participated in Psagot, the highly selective flagship program of the military's academic services and earned additional certificates in corporate analysis and valuation from Bar-Ilan University.

We are all aware of the “oldest profession in the world.” Perhaps the second-oldest is counterfeiting. Whenever a product is introduced, a counterfeit version soon follows. While the electronics industry has experienced counterfeit components from its inception, recent events such as the pandemic and supply chain shortages have fueled the counterfeit industry. Statistics by the Semiconductor Industry Association (SIA) reveal that the counterfeiting of electronic parts in the US alone cost the chip industry more than $7.5 billion in revenue annually. According to new data from the ERAI, a global information board for counterfeiting, reports of counterfeit electronic products are growing. Although it is difficult to put an exact figure on just how many counterfeit products are in circulation, estimates suggest that consumer and industrial businesses lose approximately $250 billion each year due to counterfeit parts.  To talk more about counterfeit components and detection technologies is Dr. Eyal Weiss, Founder and CTO of Cybord. Dr. Weiss received his Ph.D. in electronic and computer engineering from BGU (Ben-Gurion University) in Israel as well as a master's in plasma physics and bachelor's (cum laude) in mechanical engineering from the Technion–Israel Institute of Technology. He worked as a researcher on pulsed plasma at Soreq Research Center (SNRC). He then worked as a technology department manager in the high-tech fiber-optics industry. He was the technology manager at Lynx Photonics and then at Explay, developing state-of-the-art silicon and optical chips production, packaging, and assembly production lines. He developed a new fiber-pigtailing and packaging technology and built full-scale production lines utilizing this new technology. He returned to Soreq SNRC and for 15 years served as manager and leading scientist of the R&D Systems Department. He built mass-production lines and assembly lines for new sensors technology and developed their test equipment. He has twice received the prestigious Israel Defense Prize.  In 2018, he founded and became CTO of Cybord, developing electronic component qualification and authentication technologies. He is a member of the Israel Innovation Authority, Euramet, SAE, and IPC committees. He specializes in multidisciplinary technology development and has received significant awards and accolades in the fields of machine learning, plasma physics, optical assemblies, laser technology, and electromagnetics.  Dr. Weiss is an expert in technology development and manufacturing technology and has published over 20 peer-reviewed articles, 4 patents, and a book.     This podcast is brought to you by PCB East, the original conference for the #electronics #design, #manufacturing and #assembly industry on the East Coast. Coming to Boxborough, MA, on May 9-12, with the one-day exhibition and a day's worth of free technical sessions on May 10. Visit pcbeast.com for details.

Episode 113: A Conversation about Counterfeit Component Detection with Dr. Eyal WeissWe are all aware of the “oldest profession in the world”. Perhaps the second oldest profession is counterfeiting. Whenever a product is introduced, a counterfeit version soon follows. While the electronics industry has experienced counterfeit components from its inception, recent events such as the pandemic and supply chain shortages have fueled the counterfeit industry.Statistics by the Semiconductor Industry Association (SIA) reveal that the counterfeiting of electronic parts in the US alone, cost the chip industry more than $7.5 billion in revenue annually. According to new data from the ERAI, a global information board for counterfeiting, reports of counterfeit electronic products are growing. Although it is difficult to put an exact figure on just how many counterfeit products are in circulation, estimates suggest that consumer and industrial businesses lose approximately $250 billion each year due to counterfeit parts. To talk more about counterfeit components and detection technologies, I invited Dr. Eyal Weiss, Founder and CTO of Cybord to be my guest. Dr. Weiss received his Ph.D. in Electronic and Computer Engineering from BGU (Ben-Gurion University) in IsraelAs well as a Masters in Plasma Physics and bachelors cum laude in Mechanical Engineering from the Technion–Israel Institute of Technology.He worked as a researcher on pulsed plasma at Soreq Research Center (SNRC). He then worked as a technology department manager in the high-tech fiber-optics industry. He was the technology manager at Lynx Photonics and then at Explay, developing state-of-the-art Silicon and optical chips production, packaging, and assembly production lines. He developed a new fiber-pigtailing and packaging technology and built full-scale production lines utilizing this new technology.He returned to Soreq SNRC and for 15 years served as manager and leading scientist of the R&D Systems Department. He built mass-production lines and assembly lines for new sensors technology and developed their test equipment. He has twice received the prestigious Israel Defense Prize. In 2018, he founded and became CTO of Cybord, developing electronic component qualification and authentication technologies. He is a member of the Israel Innovation Authority, Euramet, SAE, and IPC committees. He specializes in multidisciplinary technology development and has received significant awards and accolades in the fields of machine learning, plasma physics, optical assemblies, laser technology, and electromagnetics. Dr. Weiss is an expert in technology development and manufacturing technology and has published over 20 peer-review articles, 4 patents, and a book, and, I'm happy to say, he's my guest on this episode of the Reliability Matters podcast.

Dr. Yair Shapira is the founder and CEO of Amplio. Following two decades as an executive in successful start ups, he founded Amplio to help the millions of children with special needs maximize their potential, starting with his son, who stutters. His previous roles include executive positions in sales, marketing, business development and R&D. Dr. Shapira holds a Ph.D. in Biomedical Engineering and speech processing from the Technion – Israel Institute of Technology.Luann L. Purcell, Ed.D. was the Executive Director of the international Council of Administrators of Special Education, Inc (CASE), a division of the Council for Exceptional Children (CEC) for 18 years. Dr. Purcell has 48 years of educational experience, as a general education teacher at both high school and middle school level, teacher of students with emotional and behavioral disorders, and assistant superintendent for pupil services for 18 years in a school district with 27,000 students.Judy Rich, EdD, CCC-SLP, is currently a speech-language pathologist (SLP) as well as an education consultant and lecturer at The University of Texas. She worked in public schools for 35 years as a campus SLP, program specialist for speech and language services, special education director, executive director, and assistant superintendent for student services. Angelica Morgan was most recently a Senior Curriculum Engineer at 2U and a research intern at CAST, the Center for Applied Special Technology working on the Center on Inclusive Technology in Education Systems (CITES) project. She will received her Ph.D in learning design and technology from North Carolina State University in December with a research focus on the use of technology for special education students.

For the past 20 years, Erez had led various R&D projects in the healthcare and aerospace industries. He is a well-known 3D medical imaging expert, and most recently led the development of the Itero Element Intraoral Scanner, the leading 3D dental scanner in the world. He holds a BSc & MSc in Electrical Engineering, specializing in AI, a BA in Mathematics, and an MBA, all from Technion Israel Institute of technology and Tel Aviv University and has published several patents in the field of 3D cameras in medical applications. On this episode, he discusses the low success rate of spinal surgeries, the complexity of such procedures and how the spine should be seen as a combination of many organs rather than as just one. His background as an engineer, his time as an R&D Manager at Invisalign helping to develop their 3D Camera and the set up in Infrastructure in Israel for start-ups hence why it is deemed Start-Up Nation, the common mistakes start-ups make and the importance of learning sales an entrepreneur together with being able to sell your vision, dreams, company and team Get in touch with Erez Lampert - https://www.linkedin.com/in/erez-lampert/or https://www.path-keeper.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/c/QRAMedical --- Support this podcast: https://anchor.fm/themedtechpodcast/support

Introducing engineering students to systems thinking early in their education is critical for their development and learning success. In this episode Dr. Rea Lavi talks to us about the System  Architecture-Function-Outcome (SAFO) framework he developed to help foster systems thinking in undergraduate students. He explains how this framework can be integrated in engineering teaching and used to assess systems thinking in first year engineering students.Reference(s) mentioned in this episode:Articles in peer-reviewed journals: Aubrecht, K. B., Dori, Y. J., Holme, T. A., Lavi, R., Matlin, S., Orgill, M., & Skaza-Acosta, H. (2019). Graphical tools for conceptualizing systems thinking in chemistry education. Journal of Chemical Education, 96(12), 2888-2900. Lavi, R., Dori, Y. J., Wengrowicz, N., & Dori, D. (2019). Model-based systems thinking: Assessing engineering student teams. IEEE Transactions on Education, 63(1), 39-47.Lavi, R., Dori, Y. J., & Dori, D. (2021). Assessing novelty and systems thinking in conceptual models of technological systems. IEEE Transactions on Education, 64(2), 155-162. York, S., Lavi, R., Dori, Y. J., & Orgill, M. (2019). Applications of systems thinking in STEM Education. Journal of Chemical Education, 96(12), 2742-2751. Lavi, R., Breslow, L., Salek, M. M., & Crawley, E. F. (2022, Submitted). Fostering and assessing the systems thinking of first-year undergraduate engineering students using the System Architecture-Function-Purpose framework. Other works: Presentation: Teaching and Assessing Systems Thinking in First-year Engineering Education Download link: shorturl.at/cmRUY LinkedIn article: A Cost-Effective Methodology for Tackling Ill-Defined Problems: A Case Study in an Undergraduate Project-Based Course https://www.linkedin.com/pulse/cost-effective-methodology-tackling-ill-defined-problems-rea-lavi/ResearchGate discussion: Are creative thinking and systems thinking related? https://www.researchgate.net/post/Are_creative_thinking_and_systems_thinking_relatedBio:Dr. Rea Lavi is Lecturer and a Curriculum Designer with the New Engineering Education Transformation (NEET) undergraduate program in the School of Engineering at Massachusetts Institute of Technology (MIT), Cambridge, MA, where he leads the integration of 21st century skills into the program curriculum. In 2021, he received an award from the d'Arbeloff Fund for Excellence in Education to develop and teach a new undergraduate course at MIT School of Engineering, ‘22.s092 - Tackling Challenges in Climate and Sustainability with Ways of Thinking'.Dr. Lavi received his Ph.D. in 2019 from the Faculty of Education in Science and Technology, Technion—Israel Institute of Technology, Haifa, Israel. His research interests in STEM higher education involve the fostering and assessment of systems thinking and creative thinking within the context of complex problem-solving. His doctoral research received several awards, including the Zeff Fellowship for Excelling First-year Ph.D. Students and the Miriam and Aaron Gutwirth Fellowship for Excelling Ph.D. Students. Rea's method for structured creative problem-solving, SNAP Method®, is trademarked in both the US and UK. From 2009–2013, he was involved in the founding and initial funding rounds of a biotech startup, 

Links from the show:Equal Is Unfair: America's Misguided Fight Against Income InequalityFree Market Revolution: How Ayn Rand's Ideas Can End Big GovernmentAyn Rand InstituteConnect with YaronConnect with RyanAbout my guest:Yaron Brook is chairman of the board of the Ayn Rand Institute. He wears many hats at the institute and travels extensively as ARI's spokesman.Brook can be heard on The Yaron Brook Show, which airs live on YouTube and Spreaker. He is also a frequent guest on national radio and television programs.In addition to podcasting and speaking globally, Dr. Brook authors works that inspire critical thinking. His most recent book, “In Pursuit of Wealth: The Moral Case for Finance,” makes the case that few industries are more vital to our prosperity – and more maligned – than the financial industry. Brook and coauthor Don Watkins explain why finance has faced so much criticism, and why, despite the conventional image of financiers as “greedy” and reckless, finance is a moral industry. Brook and Watkins also authored national best seller “Free Market Revolution: How Ayn Rand's Ideas Can End Big Government” and “Equal Is Unfair: America's Misguided Fight Against Income Inequality.”Above and beyond his best-selling books, Dr. Brook is a contributing author to “Neoconservatism: An Obituary for an Idea,” “Winning the Unwinnable War: America's Self-Crippled Response to Islamic Totalitarianism,” and “Big Tent: The Story of the Conservative Revolution — As Told by the Thinkers and Doers Who Made It Happen”.Brook was also a columnist at Forbes.com, and his articles have been featured in The Wall Street Journal, USA Today, Investor's Business Daily and many other publications.Brook was born and raised in Israel. He served as a first sergeant in Israeli military intelligence and earned a BSc in civil engineering from Technion-Israel Institute of Technology in Haifa, Israel. In 1987 he moved to the United States where he received his MBA and PhD in finance from the University of Texas at Austin; he became an American citizen in 2003. For seven years he was an award-winning finance professor at Santa Clara University, and in 1998 he cofounded BH Equity Research, a private equity and hedge fund manager, of which he is managing founder and director.Brook serves on the boards of the Ayn Rand Institute and on the board of the Clemson Institute for the Study of Capitalism. He is a member of the Association of Private Enterprise Education and the Mont Pelerin Society. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dispatchesfromthewarroom.substack.com

Amos is a highly experienced engineering executive who has been at the forefront of technology innovation for decades. Prior to joining Capitolis, he served as the Vice President of Research and Development at LawGeex, a company focusing on AI in the legal industry. With more than 20 years of expertise, he brings deep expertise in data, engineering, research and development, and technology, spearheading these efforts at leading technology and data companies such as Global-e, HexaTier, Cyren and Skybox Security. Amos holds a Bachelor of Science degree in Electrical and Electronic Engineering from the Technion – Israel Institute of Technology and a Master of Science degree in Electrical and Electronic Engineering from Tel-Aviv University.

For this episode we welcome back to the podcast Dr. David (Dedi) Meiri, a world-renowned cannabis researcher from the Technion - Israel Institute of Technology. With over 90 scientists working alongside Dedi on a variety of research projects at the Technion and CannaSoul, Dedi and his team tackle many of the world's most significant illnesses and conditions, including – but not limited to – cancer, inflammatory bowel disease, epilepsy and Alzheimer's. Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/ 

Eran is the CEO and Co-Founder of Juganu. Beginning his career, unconventionally, as a classical violinist, he changed direction and earned his B.Sc. in Electrical Engineering and Physics from the Technion — Israel Institute of Technology. Eran has over 15 years of experience building high-tech companies from zero to mass production. Eran is an expert in solid-state electronics and high-speed control systems, and he holds numerous patents in physics and algorithms. Juganu is his second start-up with his partner, Alex Bilchinsky. The first start-up of the two was RF Dynamics (goji). The invention was the magical oven. A technology that allows a high degree of control on rapid energy transfer to food products based on digital high-power RF components capable of modifying the frequency, amplitude, and phase of radio waves transmitted in ovens. He always brings together a wide range of tech fields to solve unmet needs - Just like he did in Juganu, which significantly impacts people's lives - for example, what they are doing lately in Philadelphia, Arlington, Mexico, Guatemala, and Brazil

This episode is a deep dive into the scientific 'cherry-picking' that Pharma companies do when promoting their ADHD drugs to parents, featuring my special guest, Israeli scientist practitioner Dr. Yaakov Ophir. Dr. Ophir is releasing his new book 'ADHD is not an illness and Ritalin is not a cure' shortly and we talked about how his own son was diagnosed at the age of 4 1/2 and told to be on Ritalin. We also further explored a ludicrous study on ADHD & Covid that he and his colleague recently wrote a scientific rebuttal to. Other topics we touched upon include: - Psychologists' & Experts' conflicts of interest - Getting attacked by Israeli ADHD experts - How Science carries the burden of proof and more... Dr. Ophir is a clinical psychologist at the mental health center of Megilot Regional Council and a research associate at the Technion – Israel Institute of Technology. His main field of research concerns the relationships between psychopathology and technology. He develops Artificial Intelligence in the age of big data and digital technology (e.g., suicide risk detection from social media through Artificial Intelligence technologies) as well as the scientific validity of Attention Deficit Hyperactivity Disorder (ADHD). Dr. Ophir published over 20 peer-reviewed scientific articles and taught several academic courses at the University of Haifa, Reichman University, and the Hebrew University of Jerusalem. Dr. Ophir received his Ph.D. from the Hebrew University of Jerusalem and he is currently working with leading world experts to develop the promising field of Cyber-psychology. His research involves computerized analyses of big-data sets and focuses on the relationships between Internet and Psychopathology. Specifically, Ophir aims to develop machine learning based tools for screening and diagnosing mental health conditions. In his clinical work, Dr. Ophir served as the director of the National Program for Children and Youth in the dead sea municipality and today he is providing short-term psychodynamic treatments as well as cognitive behavior therapies (CBT) to families and individuals in need. In the past years, following the diagnosis of his own son, Dr. Ophir delved into the field of Attention Deficit/Hyperactivity Disorder (ADHD). Through multiple writings and media interviews (mostly in Hebrew), Ophir, exposed dozens of theoretical and methodological flaws that characterize the research on ADHD and its related clinical practices. In his view, ADHD cannot be categorized as an objective brain deficit or as a psychiatric disorder and therefore he openly declares that ADHD should be removed from the Diagnostic and Statistical Manual of Mental Disorders (DSM). Original Article - https://www.haaretz.com/israel-news/2019-09-12/ty-article-magazine/.premium/adhd-is-not-an-illness-and-ritalin-is-not-a-cure/0000017f-e3ef-d75c-a7ff-ffeff8260000 The ADHD & Covid article - https://connect.springerpub.com/content/sgrehpp/early/2021/01/12/ehpp-d-20-00024 His latest MAD IN AMERIC article (ADHD/COVID SPIN) - https://www.madinamerica.com/2020/09/spin-ahead-stimulants-covid/ If you order Dr. Ophir's book now, you will receive 20% off - (use promo code: WSADHD20) https://www.worldscientific.com/worldscibooks/10.1142/12752#t=aboutBook Some empirical studies Dr. Ophir has conducted on ADHD and stimulant medications: https://connect.springerpub.com/content/sgrehpp/23/2/100 https://connect.springerpub.com/content/sgrehpp/24/1/41 Another link mentioned during this episode: The guidelines by Cortese et al. (2020) for starting ADHD medications during the COVID-19: https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30144-9/fulltext For more information on this podcast, please visit www.adhdisover.com

GUEST OVERVIEW: Dr. Shirley Zelikovsky is a trusted and attentive family physician. She is an integral part of Dr. Z's Health and Wellness Boutique, based in New York. Dr. Zelikovsky completed her medical degree from Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology. She then completed a residency in family practice from North Shore University Hospital. Dr. Zelikovsky is a board-certified family physician by the American Board of Family Medicine. Patients see her for various reasons, including flu, annual physical, illness, general consultations. She always provides comprehensive care to her patients and emphasizes preventative care for all. Dr. Zelikovsky's philosophy of practice is to assess possible contributory factors to her patient's current disease. Her clear explanations to her patients help them contribute to their healing.

#metaverse #omniverse #cto #cloudcomputing #datacenter #nvidiaWhat is the metaverse and what does it mean for you? Michael Kagan, Chief Technology Officer at NVIDIA, explains the metaverse (or omniverse, as NVIDIA calls it) and links concepts around cloud computing, data centers, digital twins, and AI.If you've wondered what the metaverse is or how our digital world is changing, you'll want to watch this interview.The conversation includes these topics:-- About Michael Kagan, CTO, of NVIDIA-- What is the metaverse or omniverse?-- On digital twin applications in the metaverse (or omniverse)-- On computing platforms and the metaverse (or omniverse)-- On AI and the metaverse (or omniverse)-- On collecting data for advanced digital simulations-- On federated learning and autonomous vehicles-- On differences between smart manufacturing digital twins and the metaverse (or omniverse)-- On cloud computing platforms, data centers, and the metaverse (or omniverse)-- On cryptocurrencies and the metaverse-- On how the metaverse (omniverse) will change distributed computing and data storageSubscribe to participate in live shows and ask questions to the guests: https://www.cxotalk.com/subscribeRead the complete transcript: https://www.cxotalk.com/episode/cto-view-cloud-metaverseMichael Kagan has been NVIDIA's CTO (Chief Technology Officer) since May 2020. He joined NVIDIA through the acquisition of Mellanox, where he was CTO and a co-founder of the company, founded in April 1999. From 1983 to April 1999, Kagan held a number of architecture and design positions at Intel Corporation. Kagan holds a BSc. in Electrical Engineering from the Technion — Israel Institute of Technology.

Yaron Daniely is a Partner & Head of aMoon Alpha and an investment leader at aMoon Velocity, an early stage investment fund that pursues dis-ruptive, cutting-edge technologies with the potential to accelerate cure. This is a fast-paced, high energy discussion from someone who has seen all sides of the ecosystem, from PhD researcher and post-doc, to entrepreneur and public company CEO, to the world of tech transfer at a top university, and who is now bridging all of the gaps in between as an investor at a fund with more than $1B AUM. We get into how he developed an interest in translational research, taking that to industry, developing curricula for scientists to learn about business, and how he helped to transform the tech transfer industry, including filling the proof of concept funding gap. He goes into how to identify what technologies and investigators have the highest chance of creating commercial success, how to incentivize tech transfer employees and increase the volume of licensing deals they do, and how to attract high-caliber entrepreneurs to join commercialization spinouts. This conversation is beyond worthwhile for anyone interested in translational research, entrepreneurship, or working in the field of technology transfer. Enjoy! More about Yaron Born in Israel and raised in Florida, Yaron was fascinated by science, medicine and tech-nology from a young age. Driven by a passion for discovering and creating novel solu-tions, and a persistent quest for challenging the status quo wherever he went, Yaron spent much of his career leading innovative health tech companies. He brings to aMoon a wealth of hands-on experience as a business leader in both the private and public sec-tors. In return, aMoon fulfills his craving for cutting-edge science and strategic thinking, applied to the creation and mentorship of young companies focused on impacting people's health. Prior to aMoon, Yaron was the President and CEO of Yissum, Hebrew University's ac-claimed Technology Transfer Company, and Co-Chairperson of the Israel Technology Transfer Network (ITTN), where he converted academic research into practical prod-ucts and technologies. Before leading Yissum, he spent 14 years as a senior executive - and 10 years as CEO - of private and NASDAQ-traded Biopharma and Biotech compa-nies. He also co-founded and served for ten years as the director of Israel's first and leading MBA program for professionals of the local Biomedical industry at the College of Management Academic Studies. Yaron earned his PhD from the Sackler Institute of Graduate Biomedical Sciences at the NYU School of Medicine. Following his doctoral program, he served as a Visiting Fel-low at the NIH, and as an American Cancer Society Postdoctoral Fellow in the Depart-ment of Molecular Cell Biology at The Weizmann Institute for Science in Israel. He also holds an MBA from the Technion - Israel Institute of Technology. Join our community of hard science researchers, grad students and entrepreneurs looking to solve global problems. Sign up on bountiful.work for more. -Follow us on Twitter (twitter.com/bountifulwork) and LinkedIn (https://www.linkedin.com/company/bountifulwork) -If you want to contribute to this effort, help us out by donating to outofthelab.eth

In this week's episode of the Future Construct Podcast (1 hour interview), we are excited to feature Joseph "Roee" Shua-Haim, Founder and CEO at Hathaware (@Hathaware). He graduated with a B.S. in Civil Engineering from the Technion Israel Institute of Technology in the summer of 2016. After graduating, Joseph moved to NYC and began his career as a structural engineer. Soon enough, Joseph took on an opportunity to shift into project management in RE development. Since making the shift, Joseph has managed over $85M in ground up developments.At Shadow Ventures, the focus is on investing in startups in tech-nascent markets where strategic capital is scarce. Their process and closed ecosystem of entrepreneurs, investors, designers, and developers are driven by both experience and technology to radically change how startups start and investors finish. In Part 2 of this podcast, we are excited to feature Thai Nguyen, Director of Virtual Design and Construction (VDC) at Hensel Phelps (@HenselPhelps). Thai has more than 20 years of experience in the architectural and construction industries. As Director of VDC, Thai drives the innovation of construction processes for Hensel Phelps, one of the United States' largest employee-owned general contracting firms. In this role he leads VDC initiatives for all of Hensel Phelps' district offices, managing a team of more than 80 individuals. This team provides company-wide leadership in VDC systems, tools and processes. They continually expand the use of virtual design and construction tools within Hensel Phelps, and within the Architecture/Engineering/Construction (AEC) industry.Highlights of Joseph and Thai's interviews with host Amy Peck (@AmyPeckXR) include:The evolution of what's being built and opportunities for mid-size companies to bring technology in and improve processesHow Joseph's developing Hathaware based on insights from conversations with customersSome of the unique challenges of bringing in new software to a large companyTalent out of the BIM world that's leading innovation, and how that may be causing a shift in new innovation roles within Hensel Phelps and other companiesSHOW NOTES 0:50  Amy Peck introduces Joseph "Roee" Shua-Haim, Founder and CEO at Hathaware.10:31  So you're here and you've created this software, you're in the accelerator program now. Where do you see the evolution of what you're building, and some of the opportunities for mid-size companies to bring technology in and improve their processes?13:25  So you also mentioned another thing that can be a trap the founders often fall into, which is too many bells and whistles, trying to make things too fancy and future rich. When you're talking to customers, what are some of the things you're hearing that are informing how you're developing Hathaware?21:18  Amy Peck introduces Thai Nguyen, Director of Virtual Design and Construction at Hensel Phelps.27:10  You mentioned some of the unique challenges of bringing in new software to a large company. There are a lot of legacy systems. Is part of your job just understanding how are you going to be able to bring in new technology and what systems do you need to alter or change to allow for all of this new technology?39:28  Your CIO and CTO are two completely different functions. I've seen this pattern of talent out of the BIM world, that's leading innovation. You're comfortable on a job site. Have you seen a shift in that, because having a CIO or CTO is pretty foreign to our industry?

Zinc deficiency linked to chronic inflammation   Oregon State University April 6 2022.    A report published in Molecular Nutrition and Food Research reveals how being deficient in the mineral zinc results in immune dysfunction and chronic inflammation, which is involved in cardiovascular disease and other conditions. Emily Ho of Oregon State University (OSU) and her colleagues examined the effects of zinc deficiency in cell cultures and aged mice. The team observed an increase in the responses of the cytokines interleukin 1beta and interleukin 6 following the administration of an inflammation-provoking substance to human white blood cells known as monocytes. In aged mice, zinc deficiency was also associated with an increase in interleukin 6 gene expression.   (NEXT)   Turmeric compound helps grow engineered blood vessels and tissues   University of California at Riverside, April 6, 2022   A finding by UC Riverside bioengineers could hasten development of lab-grown blood vessels and other tissues to replace and regenerate damaged tissues in human patients. Curcumin, a compound found in turmeric, has anti-inflammatory and antioxidant properties and is known to suppress angiogenesis in malignant tumors. Bioengineers at UC Riverside have now discovered that when delivered through magnetic hydrogels into stem cell cultures this versatile compound paradoxically also promotes the secretion of vascular endothelial growth factor, or VEGF, that helps vascular tissues grow. When cultured with stem cells derived from bone marrow, the magnetic hydrogel gradually released the curcumin without injuring the cells. Compared to hydrogels embedded with bare nanoparticles, the group of hydrogels loaded with curcumin-coated nanoparticles showed a higher amount of VEGF secretion.   (NEXT)   Exercise shown to release protein reducing bowel cancer risk   Newcastle University, April 7, 2022   Scientists at Newcastle University have shown that physical activity causes the cancer-fighting protein, interleukin-6 (IL-6), to be released into the bloodstream which helps repair the DNA of damaged cells. Previous scientific evidence suggests that more exercise is better for reducing bowel cancer risk as the more physical activitypeople do, the lower their chances of getting it. When exercise is repeated multiple times each week over an extended period, cancer-fighting substances—such as IL-6—released into the bloodstream have the opportunity to interact with abnormal cells, repairing their DNA and reducing growth into cancer."   (NEXT)   Ginkgo biloba Extract Improves ADHD Symptoms in Children   University of Tübingen's Center for Medicine (Germany), April 6, 2022   Ginkgo's usefulness for children with attention deficit/hyperactivity disorder has now been confirmed by a clinical study from Germany. This is supported by previous research showing Ginkgo's effects on cognition among the elderly. Researchers tested a Ginkgo biloba extract called EGb761 on 20 children diagnosed with ADHD in an open clinical protocol. The children were given the Ginkgo extract for three to five weeks at a dosage of up to 240 milligrams. This maximum dosage was given to those children who did not have immediate effective responses to a lower dose over the initial period of three weeks. The researchers found that the Ginkgo extract improved ADHD symptoms among the children. This improvement corresponded with improved Contingent negative variation (CNV) testing results.   (NEXT)   Pomegranate-date cocktail a day keeps the doctor away   Technion-Israel Institute of Technology , April 6, 2022   Glorious, red pomegranates and their Middle Eastern sister, luscious toffee-like dates, are delicious, increasingly trendy, and healthy to boot. As it turns out, when consumed together they are a winning combination in the war against heart disease. Just half a glass of pomegranate juice a day with a handful of dates can do the trick! A team of researchers at the Technion-Israel Institute of Technology has discovered that the combination of pomegranate juice and dates along with their pits provide maximum protection against atherosclerosis (plaque buildup or hardening of the arteries), which can cause a heart attack or stroke. Pomegranate juice, rich in polyphenolic antioxidants (derived from plants), has been shown to most significantly reduce oxidative stress. Dates, which are rich sources of phenolic radical scavenger antioxidants, also inhibit the oxidation of LDL (the so-called "bad cholesterol") and stimulate the removal of cholesterol from lipid-laden arterial cells. Dr. Richard Fleming Dr. Richard Fleming is a cardiologist specializing in nuclear medicine who has proven a direct correlation between inflammation and heart disease.  Dr. Fleming holds a PhD in particle physics, graduated from the University of Iowa College of Medicine and later completed a law degree. He is the inventor of the Fleming Method for Tissue and Vascular Differentiation and Metabolism, a method that quantifies tissue activity due to inflammation and infection. In the past Richard has taught at the University of Texas and conducted cardiological research at Methodist College and Creighton University. Since the declaration of the Covid pandemic, he has put his attention on uncovering the health risks from both the SARS-2 virus and the Covid-19 vaccines, exposing the medical risks, and researching the genetic engineered origins of SARS-2.  He has published and edited several medical texts and has published over 60 peer-reviewed scientific papers. He recently released a new book "Is Covid-19 a Bioweapon: A Scientific and Forensic Investigation," which takes a hard critical look at the available evidence that identifies clear genetic anomalies that could only have occurred through gain of function research.  Dr Fleming's website is FlemingMethod.com.

Vitamin K shows evidence of brain benefits  Study suggests a biological pathway through which vitamin K may help ward off dementia  AlMaarefa University(Saudi Arabia), April 5, 2022 In a new study conducted in rats, scientists report evidence that vitamin K could help protect against aging-related cognitive declines associated with Alzheimer's disease and other forms of dementia. Vitamin K2 demonstrated very promising impact in hindering aging-related behavioral, functional, biochemical and histopathological changes in the senile aging brain. Vitamin K2 can be proposed to be a promising approach to attenuate age-related disorders and preserve cognitive functions in aging individuals. The researchers used validated tests including a maze, swim test and sociability test to assess the rats' cognitive functioning and depressive-like and anxiety behavior. These tests revealed that rats that received MK-7 performed better than those that did not. Vitamin K supplementation was associated with reduced evidence of cognitive impairment, depression and anxiety, along with improved spatial memory and learning ability. (Next) Vegetarian Diet Reduces Risk Of Heart Disease By A Third University of Oxford, March 30, 2022    A vegetarian diet can reduce a person's risk of heart disease by a third. Vegetarians have a 32% lower risk of hospitalization or death from cardiovascular disease than people who consume meat and fish. The study is the largest yet to compare cardiovascular disease rates between vegetarians and meat eaters. The experts analyzed nearly 45,000 participants (34% were vegetarian) from England and Scotland who signed up for the European Prospective Investigation into Cancer and Nutrition (EPIC)-Oxford study. (NEXT) Meditation builds brain cells, Harvard study shows proof Harvard University, April 2, 2022 Research has now demonstrated that meditation builds brain cells and increases gray matter in the brain. Using magnetic imaging (MRI), Harvard researchers found that meditation produced physiological changes in the brain's gray matter. Some areas in the brains of the study participants thickened after only eight weeks of mindfulness practice. Study participants reported feeling less stressed after the eight-week period. MRI scans revealed decreased gray matter in the amygdalae and increased gray matter in the hippocampus. The amygdalae are the parts of the brain that help the body deal with anxiety and stress and controls the “fight or flight” mechanism. The hippocampus, which showed an increase in gray-matter density, is the area of the brain that controls memory, learning, self-awareness, introspection and compassion. (NEXT) Artificial sweeteners linked with a 13% higher risk of cancer Sorbonne Paris Nord University, March 31, 2022 A large new observational study has found an association between the consumption of artificial sweeteners, particularly aspartame and acesulfame-K, and cancer. The study found a 13% higher risk of cancer in general, with the highest likelihood of developing breast cancer and cancers related to obesity, for people consuming large quantities of artificial sweeteners. The researchers analyzed the histories of 102,865 adults participating in the ongoing NutriEnt-Santé studyTrusted Source that began collecting data in 2009. Participants were followed for the new research over an average of 7.8 years. Senior investigator and director of EREN Dr. Mathilde Touvier said to MNT: “We performed analyses for the ‘total of artificial sweeteners' overall (i.e., the sum of acesulfame-K, aspartame, sucralose, cyclamates, saccharin, steviol glycosides, and salt of aspartame-acesulfame), and then separately for the most represented artificial sweeteners in the cohort (i.e., acesulfame-K, aspartame, and sucralose).” Looking deeper into the greater risk of Aspartame and acesulfame-K, Dr. Touvier explained, “It should be noted that aspartame and acesulfame-K were by far the most frequently consumed artificial sweeteners.” (NEXT) Israeli Study: Your Cell Phone Is Killing Your Sperm Technion-Israel Institute of Technology and Carmel Medical Center (Israel), April 2, 2022 Over the years, science has thoroughly documented the global decline in male fertility, which has been ongoing since the 1940s. Several possible culprits have been blamed such exposure to pesticides, estrogen-mimicking chemicals, and sedentary lifestyles. However, a team of Israeli scientists has found another possible environmental cause. Researchers at Haifa's Technion- Israel Institute of Technology and Carmel Medical Center, conducted a study involving 106 men who were given a semen analysis. They have found that men who wear their cell phones in their pants pockets, have significantly higher rates of abnormal sperm. 47% of men who stored their cell phones in their pants had abnormal sperm, compared to just 11% for the average male. But keeping a cell phone near the groin wasn't the only contributing factor to poor fertility. Both talking on the phone for more than an hour a day and using it while it was charging, was also linked to abnormal sperm counts. Videos Clips:  Doctor Exposes The Corruption Of Food Science (Pt. 2) | Dr. Mark Hyman | LIFESTYLE  (8:55 Long) 2. FAUCI In His Own Words  3. “is about something called furries.” 4. Ben Swann : Hunter Biden invested in and raised money for Bio Labs  5. An Economic Hit Man Confesses and Calls to Action | John Perkins | TEDxTraverseCity (18:35 Long)     Articles : No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant Freedom and Ivermectin prevail Farewell, University of California WSJ Misleads Public on Ivermectin, Ignores Latest Revelations About ‘Hidden Author' Who Undermined Its Efficacy The great Aids scam – a dry run for Covid Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure

Zohar Halachmi is the Chairman and CEO at D-Fend Solutions. Before co-founding D-Fend Solutions, he was the founder and CEO of two mobile and enterprise application start-up companies. He also held VP and C-level positions at Amdocs and ECI Telecom (global and public telecommunication enterprises). While managing multi-disciplinary large- and small-scale organizations, Zohar created fast-growth and profitable businesses, bringing innovative solutions and services to the market. He graduated cum laude with a B.Sc. from the Technion – Israel Institute of Technology and M.Sc. from Tel Aviv University, and was a lecturer at both institutions.

This episode features an interview with Tomer Shiran, Founder and Chief Product Officer at Dremio. Dremio is a high-performance SQL lakehouse platform that helps companies get more from their data in the fastest way possible. Prior to Dremio, Tomer served as VP of Product at MapR and also held product management and engineering roles at Microsoft and IBM Research. He also has a master's degree from Carnegie Mellon University as well as a bachelor's from Technion - Israel Institute of Technology.In this episode, Tomer and Sam dive into the economics of storing data, how to build an open architecture, and what exactly a data lakehouse is.-------------------“I think in the world of data lakes and lakehouses, the model has shifted upside down. Now, instead of bringing the data into the engines, you're actually bringing the engines to the data. So you have this open data tier built on open source technology. The data is represented in open source formats and stored in the company's S3 account or Azure storage account. And then you can use a variety of engines. We at Dremio, we take pride in building the best SQL engine to use on the data. There are different streaming engines, like Spark and Flink. There are different batch processing and machine learning engines. Spark is an example of that as well that companies can use on that same data. And I think that's one of the really important things from a cost standpoint, too, is that this really lowers your overall costs, both today and also in the future as you scale.” – Tomer Shiran-------------------Episode Timestamps:(02:04): What open source data means to Tomer(03:14): Tomer's motivation behind Apache Arrow(06:42): How Tomer solved data accessibility (08:43): The unit economics of storing data(14:31): Tomer's motivations for Iceberg and how it relates to Project Nessie(17:06): What is a data lakehouse?(18:31): What gives Dremio its magic?(23:39): What cloud data architecture will look like in 5 years(27:19): Advice for building an open data architecture-------------------Links:LinkedIn - Connect with TomerLinkedIn - Connect with DremioTwitter - Follow TomerTwitter - Follow DremioVisit DremioGet started with Dremio

Jacques Botbol is an international marketer with an engineer's mind and an entrepreneurial spirit. He is currently the VP of Marketing at Verbit, an innovative transcription and captioning solution with a guarantee of 99% accuracy. Jacques also has experience as the Head of Marketing and Strategy at Panorama Software and as a leader in the Business Development department at TIGI. He received both his bachelor's and master's degrees from Technion - Israel Institute of Technology. In this episode… Businesses don't grow by accident. Any thriving company is the result of hard work, vision, and great marketing. More specifically, it takes the right strategy to make those three elements work as they should. Developing a comprehensive and effective strategy isn't simple, leaving few people who have the skills to turn potential into reality. If anyone fills that criteria, it's Jacques Botbol. Jacques is a marketing leader for Verbit, helping the company grow and scale within a short period of time. His background in business development and engineering helps him create strategies that others may not consider. With a successful track record, he shares some of his insights with you. Alex Gluz brings on Jacques Botbol, the VP of Marketing at Verbit, to discuss digital marketing and strategy. The two dive into topics such as choosing a vertical, adapting an acquisition strategy, and creating the right messaging. They also touch on Jacques' career and the mentors who helped him along the way. Hear all of this and more on the Revenue Engine Podcast.

The Smart 7 Ireland Edition is the daily news podcast that gives you everything you need to know in 7 minutes, at 7am, 7 days a week… Consistently appearing in Ireland's Daily News charts, we're a trusted source for people every day. If you're enjoying it, please follow, share or even post a review, it all helps… Today's episode includes the following guests: Professor Asya Rolls - Associate Professor at Technion Israel Institute of TechnologyTamar Koren - MD & PhD candidate at Technion Israel Institute of TechnologyDr Indroneel Chatterjee - Senior Lecturer in Consumer Behaviour and Marketing, Oxford Brookes UniversityLiz Madara - CEO at PoliloopDavid Townsend - Founder and CEO of Townrock EnergyDr Martin Worthington - Associate Professor in Middle Eastern Studies at Trinity College DublinNadav Mansdorf - High Hopes Labs founder and CEO Roxanne Felig - Social Psychology PhD student at the University of South Florida Contact us over at Twitter or visit www.thesmart7.com Presented by Ciara Revins, written by Liam Thompson and produced by Daft Doris. See acast.com/privacy for privacy and opt-out information.

Subscribe: iTunes, Android, Spotify, Stitcher, Google, and RSS.In this episode of the Data Exchange I speak with Kira Radinsky, Chairwoman & Chief Technology Officer at Diagnostic Robotics, a startup using AI to build a medical-grade triage and clinical-predictions platform. She is also a visiting Professor at Technion – Israel Institute of Technology.  Kira has extensive experience using data science and machine learning in a variety of settings, and she was one of the pioneers in using alternative data sources to augment forecasting models. Her earlier work includes models to predict social unrest as well as disease outbreaks.  The global pandemic has increased the need for experts in medical data mining, a field where Kira has made many significant contributions to.Download the 2020 NLP Survey Report and learn how companies are using and implementing natural language technologies.Detailed show notes can be found on The Data Exchange web site.Subscribe to The Gradient Flow Newsletter.

Dror brings to Norwest more than 20 years of operational, technology and entrepreneurial experience, having worked extensively in both the U.S. and in Israel in various senior positions at leading global organizations. Dror most recently invested in and serves on the boards of CyberX, Cynet, Gong, Personali, SundaySky, VAST Data, Weka.IO, and Wiliot. Dror has served as a board member of Veraz Networks since 2004. Dror was a previous board participant at Fireglass (acquired by Symantec), Pontis (acquired by Amdocs), ScaleIO (acquired by EMC), Seculert (acquired by Radware), SolarEdge (Nasdaq: SEDG) Unisfair (acquired by InterCall), and Velostrata (acquired by Google) and was a board observer for ConteXtream (acquired by HP). At Norwest, Dror focuses on multi-stage (seed to pre-IPO) and multi-domain (enterprise, cloud, consumer, semi) investments in Israel. Prior to joining Norwest, Dror served as executive vice president and Chief Strategy Officer of ECI, which he joined in 2004. In this role, he was responsible for ECI's strategy, mergers and acquisitions, business development, and strategic marketing. Before joining ECI, Dror was CEO of Axonlink, an optical components start-up company. Prior to Axonlink, he was President of I-Link, a US-based VoIP service provider which acquired MiBridge, the VoIP software company he founded. Dror was also a senior research engineer at AT&T Bell Labs where he developed voice and video compression technologies, including the speech coder that is now the standard for CDMA cellular in North America. Dror holds a BSc in electrical engineering from the Technion – Israel Institute of Technology, Haifa. About The Project EGG Show: The Project EGG Show is a video talk show that introduces you to entrepreneurs from around the world. It is broadcast from studios in Metairie, Louisiana to online platforms including YouTube, iTunes, Google Play, Spotify and Stitcher, and hosted by Ben Gothard. Our goal is to give you a fresh, unscripted and unedited look into the lives of real entrepreneurs from around the globe. From billionaires to New York Times best selling authors to Emmy Award winners to Forbes 30 Under 30 recipients to TEDx speakers – we present their real stories – uncensored and uncut. Subscribe To The Show: https://projectegg.co/podcast/ Get Access To: 1. Resources: https://projectegg.co/resources/ 2. Financing Solutions: https://projectegg.co/epoch/ 3. Payment Solutions: https://projectegg.co/sempr/ 4. Services: https://projectegg.co/resources#services 5. Courses: https://projectegg.co/resources#courses 6. Software: https://projectegg.co/resources#software 7. Book: https://projectegg.co/resources#books --- Support this podcast: https://anchor.fm/projectegg/support